Integrative data mining to identify novel candidate serum biomarkers for pre-eclampsia screening

Area of Science:

• Biochemistry
• Genomics
• Obstetrics

Background:

• Pre-eclampsia (PE) affects 2% of pregnancies globally, lacking reliable early screening tests for timely intervention.
• Current diagnostic methods for PE are insufficient for early detection in screening settings.
• Understanding PE etiology, including impaired trophoblast invasion, is crucial for biomarker discovery.

Purpose of the Study:

• To develop a comprehensive list of candidate serum biomarkers for early detection of pre-eclampsia (PE).
• To aid future experimental identification and validation of reliable PE screening biomarkers.
• To leverage data mining for discovering novel biomarkers for early-onset PE.

Main Methods:

• Applied a three-stage filtering strategy: tissue-specific gene selection, text mining for gene prioritization, and identification of blood-detectable markers.
• Utilized disease etiology, specifically impaired trophoblast invasion, as a basis for the filtering process.
• Employed a data mining approach to systematically identify potential serum biomarkers.

Main Results:

• Generated a list of 38 candidate biomarkers for PE.
• The list includes established first-trimester biomarkers: LGALS13 (PP13), PAPPA (PAPP-A), and PGF (PlGF).
• The approach successfully identified previously known biomarkers and suggests the presence of novel candidates.

Conclusions:

• The generated list of candidate biomarkers is valuable for prioritizing future experimental studies.
• This data mining approach effectively substantiates the identification of potential serum biomarkers for early-onset PE.
• The findings provide a foundation for developing more reliable early detection methods for PE.